UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

                           MAY 17, 2007 (MAY 11, 2007)
                Date of Report (Date of earliest event reported)

                              DELCATH SYSTEMS, INC.
             (Exact name of registrant as specified in its charter)

           DELAWARE                    001-16133                 06-1245881
 (State or other jurisdiction    (Commission File No.)         (IRS Employer
      of incorporation)                                     Identification No.)

                               1100 SUMMER STREET
                               STAMFORD, CT 06905

          (Address of principal executive offices, including zip code)

       Registrant's telephone number, including area code: (203) 323-8668


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligations of the registrant under any of the
following provisions (see General Instruction A.2. below):

|_|  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)


|_|  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)


|_|  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))


|_|  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))







ITEM 3.01. NOTICE OF DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR
STANDARD; TRANSFER OF LISTING.

     On May 11, 2007, Delcath Systems, Inc. (the "Company") received a letter
from the Boston Stock Exchange (the "BSE") stating that, based on the BSE's
review of the Company's recent filings, and due to the recent changes in the
composition of the Company's Board of Directors, the Company is not in
compliance with the BSE requirements to have a majority of independent directors
on its Board of Directors, or as to the composition of the Company's audit
committee. The BSE also notified the Company that it has a cure period until the
earlier of the next shareholders' meeting, or if such meeting is before October
13, 2007, it has until October 13, 2007, to evidence compliance. As the
Company's next shareholders' meeting is scheduled to be held on June 5, 2007,
the Company has until October 13, 2007 to evidence compliance.

     On May 16, 2007, the Company confirmed to the BSE that it recognizes its
non-compliance with these BSE requirements, and informed the BSE that it would
file this Current Report on Form 8-K to disclose such non-compliance.

     This letter from the BSE follows a letter the Company recently received
from the NASDAQ Stock Market("NASDAQ") as to its compliance status on the NASDAQ
Capital Market ("NCM") for the same reasons. As indicated in the Company's
previous filing relating to the NASDAQ notice, the Company is actively seeking
one or more additional members for its Board of Directors, and fully intends to
regain compliance with the BSE and NASDAQ rules within the cure period allowed.

ITEM 8.01. OTHER EVENTS.

     Due to the Securities and Exchange Commission's recent adoption of an
amendment to Rule 146 under the Securities Act of 1933, as amended (the
"Securities Act"), which designates securities listed on the NCM as covered
securities for purposes of Section 18 of the Securities Act, the Company would
no longer need to maintain the listing of its securities on the BSE following
effectiveness of the amendment, in order to qualify for exemption from blue sky
registration requirements in certain states. Accordingly, as the Company's
securities are listed on the NCM, the Company is considering withdrawing the
listing of its securities on the BSE.





                                   SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this Current Report on Form 8-K to be
signed on its behalf by the undersigned thereunto duly authorized.


Dated: May 17, 2007                               DELCATH SYSTEMS, INC.

                                            By:   /s/ Richard Taney
                                                  ------------------------------
                                                  Name:  Richard Taney
                                                  Title: Chief Executive Officer